1 chart shows how quickly a booster shot can improve immunity, with some extra protection in just a few days

  • In Science
  • 2021-11-24 19:20:19Z
  • By Business Insider
a pregnant woman, sitting and clutching her belly, getting a covid 19 booster shot stuck into her arm.
a pregnant woman, sitting and clutching her belly, getting a covid 19 booster shot stuck into her arm.  
  • Booster shots are being offered to all US adults.

  • Studies suggest boosts can improve protection against symptomatic COVID-19, at least temporarily, with benefits beginning to accrue after a few days.

  • It's unknown how durable booster shot protection will be, but scientists are hopeful.

Two shots are good, but when it comes to preventing symptomatic COVID-19 infections, three may be even better.

It's tough to say what the long-term benefit of coronavirus booster shots will be, because no one has had COVID-19 boosts in their system for long. But immunologists generally agree that boosting people many months after they are first vaccinated gives a jolt to the immune system.

Early-stage booster shot studies from around the world are starting to suggest that the protection people get when they have an additional shot months after their first vaccination course is more potent, sending antibody levels soaring to new heights, and (at least temporarily) bolstering protection against COVID-19.

Take the data available from Pfizer's booster shot trial, which recruited roughly 10,000 people who were fully vaccinated with two shots of the company's COVID-19 vaccine. Trial participants were split into two groups: about 5,000 got boosted, while the other 5,000 recieved a fake (placebo) jab with no extra vaccine inside.

It didn't take long to spot the difference between boosted and unboosted vaccinated people in the trial. As Pfizer showed in the chart below, which was recently shared with advisors to the Centers for Disease Control and Prevention, booster shot recipients start benefitting from increased protection against symptomatic coronavirus infections just a few days after their third dose.

chart from pfizer
chart from pfizer's booster study showing boosted people with far fewer covid 19 cases than unboosted people  

"If you look at the blue, it's what happens after you get the third dose booster shot," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said on Monday during a White House briefing, explaining how to read the chart, which tracked the number of symptomatic coronavirus infections among Pfizer's trial participants for 100 days after they were jabbed.

Fauci pointed out the people who had boosts in Pfizer's trial (blue line) had a far lower incidence of COVID-19 than those with just two shots who received a fake, placebo shot (red line).

"Unequivocally, effect of the booster shot," Fauci said.

Improved protection against symptomatic COVID-19 ramps up in about a week or two

According to Pfizer, the relative vaccine efficacy of the booster shot is 95% here. That means 95% of the people in the Pfizer trial who got sick with COVID-19 were vaccinated but not boosted, while the other 5% of sick people were boosted. (Scientists started tallying symptomatic COVID-19 cases starting seven days after the boosts were given out, and continued doing so until day 100.)

But you don't have to take Pfizer's word for it.

A landmark National Institutes of Health trial mixed and matched people who'd gotten Pfizer, Moderna, and Johnson & Johnson vaccines into different booster groups and found that no matter which combination of initial vaccine and booster people had, their antibody levels soared (suggesting better protection against infections), with improvements peaking at around two weeks post-boost.

Another study conducted in the UK (which is still under scientific review) found booster shots given out starting in September, for both Pfizer and AstraZeneca recipients, increased vaccine effectiveness in people over age 50 to more than 93%, a dramatic improvement. And data from Israel suggests that at 12 days post-boost, the rate of infection among booster shot recipients plummets to 11 times lower than that of fully vaccinated people, and the rate of severe illness goes down more than 19-fold among booster recipients.

Across the board, a trend is becoming clear. Booster shots amp up our immune response, making it less likely boosted people will get sick with COVID-19 - at least for a while.

But vaccine experts also stress that it's important to remember the blockbuster benefits of a booster shot will likely wane over time. Boosts may be a good idea before people gather for the holidays, but they won't last forever.

"It's just kind of a normal part of our immune system that after vaccination, or exposure, our antibody levels go way up, and then they come down over time," Dr. William Moss, executive director of the International Vaccine Access Center at Johns Hopkins University, told Insider. "They have to come down, or else our blood would just fill with antibodies."

Fortunately, vaccination also promotes a more enduring memory immune response that lasts for many months longer than the antibodies do, which means that even if vaccinated people do get a little sick , they are generally well-protected against the worst that COVID-19 can do.


More Related News

German parliament to debate job-specific vaccine mandate
German parliament to debate job-specific vaccine mandate
  • US
  • 2021-12-07 09:15:25Z

Germany's parliament is set to debate a proposed vaccine mandate for hospital and nursing home staff on Tuesday, among other measures meant to help break the...

Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study
Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study
  • US
  • 2021-12-06 23:40:26Z

A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or...

Omicron may raise re-infection risk; booster protection documented
Omicron may raise re-infection risk; booster protection documented
  • US
  • 2021-12-06 20:54:41Z

Survivors of previous infection with the virus that causes COVID-19, known as SARS-CoV-2, may be at higher risk for re-infection with the Omicron variant...

New York City mandates shots for all private businesses amid Omicron spread
New York City mandates shots for all private businesses amid Omicron spread
  • US
  • 2021-12-06 17:45:08Z

NEW YORK (Reuters) -New York City declared on Monday that all private-sector employers must implement COVID-19 vaccine mandates for their workers, as the...

South Africa
South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec
  • US
  • 2021-12-06 13:59:02Z

KIGALI (Reuters) -South Africa's Biovac Institute will start making Pfizer-BioNTech's COVID-19 vaccine early next year after receiving the drug substance...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Science